Find uplifting stories about heroes, innovations, and solutions
57 results for "ptsd"
A groundbreaking surf therapy program in Queensland is helping female veterans overcome PTSD and trauma by combining ocean waves with mental health support. The retreat, believed to be the first of its kind in Australia for female veterans, has already been called "life-changing" by participants.
A new AI platform called Lucy is solving a critical shortage in psychedelic therapy by training facilitators using real-world data from thousands of support calls. Built from a database of actual psychedelic experiences, Lucy helps prepare therapists for the emotional challenges of guiding patients through breakthrough mental health treatments.
A shipping container with three mobile floatation tanks is heading to Maui to help survivors of the 2023 wildfires that left thousands struggling with PTSD and anxiety. If successful, these spa-like therapy pods could become standard equipment in disaster zones worldwide.
Twenty volunteers spent their day repairing and cleaning Camp Liberty, a Michigan retreat designed specifically for veterans with PTSD and mobility challenges. The camp offers fully accessible trails and a space where veterans can find community, healing, and simple joy.
A breakthrough treatment using psilocybin-assisted therapy is nearing FDA approval, offering hope to millions with treatment-resistant depression and PTSD. After decades without new psychiatric treatments, this could revolutionize how we heal mental illness.
A single treatment with ibogaine, a powerful plant-based compound, helped 30 special forces veterans significantly reduce their PTSD symptoms in a Stanford University study. The promising results offer new hope for military veterans struggling with trauma and mental health challenges.
A groundbreaking trial shows military veterans experiencing dramatic improvements in PTSD symptoms after just one session with ibogaine, a powerful natural psychedelic. The research could open new doors for millions struggling with treatment-resistant trauma.
UC Davis researchers have developed new compounds that could treat depression and PTSD with the healing power of psychedelics but without hallucinations. The breakthrough discovery uses simple amino acids and UV light to create an entirely new class of mental health treatments.
Patrina Ross survived four combat deployments, breast cancer, and devastating personal loss to graduate from Virginia State University this weekend. Her journey from Army chef to honors student proves that determination can overcome any obstacle.
Over 60% of U.S. voters now strongly support making psychedelics easier to study for medical use, a 14-point jump from 2023. The shift reflects growing public curiosity about therapeutic benefits of substances like psilocybin and MDMA.
Australian trauma surgeon Herwig Drobetz is heading back to Gaza's Rafah Field Hospital for his fourth mercy mission, even after developing PTSD from working in an active war zone. His dedication shows how one doctor's courage continues to bring hope to thousands still recovering from conflict.
The FDA is accelerating reviews of three psychedelic medications for depression and PTSD, moving promising mental health treatments closer to patients who desperately need them. Millions struggling with treatment-resistant conditions could soon have groundbreaking new options.
Three psychedelic treatments for depression and PTSD could receive FDA approval as soon as this summer, potentially offering hope to millions struggling with mental health conditions. The accelerated review process cuts approval time from a year down to just weeks.
The FDA is accelerating breakthrough psychedelic therapies for treatment-resistant depression, PTSD, and alcohol use disorder after a presidential directive. Veterans and millions struggling with serious mental illness could gain access to promising new options backed by rigorous science.
The FDA is accelerating approval for psilocybin and MDMA-like therapies to treat depression and PTSD, potentially opening new doors for millions struggling with mental health conditions. Three companies are now on an expedited path to bring these promising treatments to patients who haven't found relief from traditional options.
President Trump signed an executive order to expand access to psychedelic therapies for conditions like PTSD, depression, and addiction. The move signals growing mainstream acceptance of treatments once considered fringe medicine.
A presidential order is accelerating research on ibogaine, a plant-based treatment showing promise for veterans with PTSD and people battling depression. The FDA says approval could come within months instead of years.
A new executive order accelerates research into psychedelic medicines for mental illness, prioritizing veterans facing treatment-resistant PTSD and depression. The move ends decades of federal prohibition and could offer hope to the 17 veterans who die by suicide every day.
Virginia lawmakers just passed groundbreaking legislation to help veterans struggling with depression and PTSD. Once the FDA approves psilocybin-based medicine, veterans will have immediate legal access to this promising treatment.
Researchers in San Antonio have successfully treated combat PTSD in 85% of patients using magnetic brain stimulation alongside therapy. The breakthrough offers hope to millions of veterans and active-duty service members living with severe trauma.
Showing 20 of 57